| Announce Date | 11/12/2025 |
| EPS Normalized Actual | $-0.32 (Beat by $0.51) |
| EPS GAAP Actual | $-0.32 (Beat by $0.51) |
| Revenue Actual | $0.003453B |
| Revenue Surprise | Beat by $3.453M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.09 |
| EPS GAAP Estimate | $2.09 |
| Revenue Estimate | $0.0427465B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | -7.79333 | -0.63 | -12.18341 | -2.75392 | 1 |
| Dec 2028 | -0.2 | -24.4 | -0.36686 | -0.03006182 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.32 | -0.05 | 0.003453B | -1063.92% | -6.45M |
| FQ2 2025 (Jun 2025) | 0.2 | 6.95 | 0B | -INF% | -9.9M |
| FQ1 2025 (Mar 2025) | 3.53 | 4.655 | 0B | -INF% | -34.7M |
| FQ4 2024 (Dec 2024) | -1.19 | -1.04 | 0.032753B | 87.02% | 7.86M |
| FQ3 2024 (Sep 2024) | -2.93 | -2.8075 | 0.04019B | 94.68% | 7.98M |
| FQ2 2024 (Jun 2024) | -3.1 | -4.43835 | 0.02864B | 96.66% | 24.9M |
| FQ1 2024 (Mar 2024) | -0.23 | -0.23 | 0.027357B | 95.52% | 27.36M |
| FQ4 2023 (Dec 2023) | -0.56 | -0.56 | 0.004252B | 100% | 4.25M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.09
Consensus Revenue Estimates
0.0427465B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.49 | -- | -0.49 | -0.49 | 1 |
| FQ3 2026 (Sep 2026) | -0.52 | 38.46 | -0.52 | -0.52 | 1 |
| FQ2 2026 (Jun 2026) | -0.57 | 135.09 | -0.57 | -0.57 | 1 |
| FQ1 2026 (Mar 2026) | 2.09 | -68.9 | 2.09 | 2.09 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 2 |
| FQ3 2026 (Sep 2026) | 0B | 9.42 | 0B | 0B | 2 |
| FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 2 |
| FQ1 2026 (Mar 2026) | 0.04B | -- | 0.04B | 0.04B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.27 | -0.32 | -0.05 | 15.63% |
| FQ2 2025 (Jun 2025) | -6.75 | 0.2 | 6.95 | 3475% |
| FQ1 2025 (Mar 2025) | -1.125 | 3.53 | 4.655 | 131.87% |
| FQ4 2024 (Dec 2024) | -0.15 | -1.19 | -1.04 | 87.39% |
| FQ3 2024 (Sep 2024) | -0.1225 | -2.93 | -2.8075 | 95.82% |
| FQ2 2024 (Jun 2024) | 1.33835 | -3.1 | -4.43835 | 143.17% |
| FQ1 2024 (Mar 2024) | -0.23 | -0.23 | 100% | |
| FQ4 2023 (Dec 2023) | -0.56 | -0.56 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.01B | $0B | $-6.45M | -186.71% |
| FQ2 2025 (Jun 2025) | $0.01B | $0B | $-9.9M | -INF% |
| FQ1 2025 (Mar 2025) | $0.03B | $0B | $-34.7M | -INF% |
| FQ4 2024 (Dec 2024) | $0.02B | $0.03B | $7.86M | 24.01% |
| FQ3 2024 (Sep 2024) | $0.03B | $0.04B | $7.98M | 19.85% |
| FQ2 2024 (Jun 2024) | $0B | $0.03B | $24.9M | 86.94% |
| FQ1 2024 (Mar 2024) | $0B | $0.03B | $27.36M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $4.25M | 100% |